Fig. 1.
Study profile (a) and distributions of HBV biomarkers throughout 72 weeks (b). Scatter plots of HBV RNA, HBV DNA, HBsAg, and HBeAg were shown in five groups: (1) all patients; (2) SR patients who achieved HBeAg seroconversion; (3) Non-SR patients who failed to achieve HBeAg seroconversion; (4) HBsAg loss patients who achieved HBsAg loss; and (5) non-HBsAg loss patients who failed to achieve HBsAg loss. Mean values were linked by red lines